Jones Trading Maintains Buy on Contineum Therapeutics, Raises Price Target to $30

Benzinga · 1d ago
Jones Trading analyst Debanjana Chatterjee maintains Contineum Therapeutics (NASDAQ:CTNM) with a Buy and raises the price target from $24 to $30.